全文获取类型
收费全文 | 4857篇 |
免费 | 193篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 115篇 |
妇产科学 | 175篇 |
基础医学 | 468篇 |
口腔科学 | 54篇 |
临床医学 | 385篇 |
内科学 | 1418篇 |
皮肤病学 | 82篇 |
神经病学 | 661篇 |
特种医学 | 140篇 |
外科学 | 640篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 156篇 |
眼科学 | 143篇 |
药学 | 233篇 |
中国医学 | 22篇 |
肿瘤学 | 297篇 |
出版年
2023年 | 47篇 |
2022年 | 91篇 |
2021年 | 147篇 |
2020年 | 94篇 |
2019年 | 104篇 |
2018年 | 141篇 |
2017年 | 94篇 |
2016年 | 120篇 |
2015年 | 119篇 |
2014年 | 191篇 |
2013年 | 235篇 |
2012年 | 367篇 |
2011年 | 345篇 |
2010年 | 218篇 |
2009年 | 201篇 |
2008年 | 328篇 |
2007年 | 284篇 |
2006年 | 266篇 |
2005年 | 285篇 |
2004年 | 229篇 |
2003年 | 220篇 |
2002年 | 199篇 |
2001年 | 73篇 |
2000年 | 65篇 |
1999年 | 61篇 |
1998年 | 44篇 |
1997年 | 27篇 |
1996年 | 32篇 |
1995年 | 40篇 |
1994年 | 26篇 |
1993年 | 13篇 |
1992年 | 40篇 |
1991年 | 42篇 |
1990年 | 33篇 |
1989年 | 32篇 |
1988年 | 29篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 21篇 |
1984年 | 22篇 |
1983年 | 14篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1975年 | 4篇 |
1974年 | 7篇 |
1965年 | 3篇 |
排序方式: 共有5078条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
The aim of this study was to investigate the role of plasma glucagon levels on the blood glucose response to intravenous insulin administered continuously or in a pulsatile manner. Six type I diabetic patients proven to have no residual insulin secretion were investigated. Endogenous glucagon secretion was inhibited by a continuous intravenous infusion of somatostatin (100 micrograms/h) and replaced by exogenous infusions of the hormone at three different rates (7.5, 4.5, and 2.5 micrograms/h), resulting in three different plasma glucagon steady-state levels (i.e., approximately equal to 200, approximately equal to 130, and approximately equal to 75 pg/ml, respectively). Each subject, in random order and on different days, was infused intravenously with regular human insulin either continuously (0.17 mU X kg-1 X min-1) or with the same amount of insulin infused in a pulsatile manner (0.85 mU X kg-1 X min-1 during 2 min followed by 8 min during which no insulin was infused). At plasma glucagon levels approximately equal to 200 pg/ml, blood glucose rose from approximately 10 to approximately 13 mM without any difference between the two modalities of insulin infusion. For plasma glucagon levels approximately equal to 130 pg/ml, plasma glucose remained steady throughout the experiments, but during the last 40 min, plasma glucose levels were significantly lower when insulin was administered intermittently. This greater blood glucose-lowering effect of pulsatile insulin occurred earlier and was more pronounced for plasma glucagon levels averaging 75 pg/ml. We conclude that the greater hypoglycemic effect of insulin administered intravenously in a pulsatile manner in type I diabetics critically depends on plasma glucagon circulating levels. 相似文献
5.
Giuseppina Di Stefano Luigi Fiume Michele Baglioni Corrado Busi Pasquale Chieco Felix Kratz Alessandro Mattioli 《European journal of pharmaceutical sciences》2007,30(2):136-142
Several attempts have been made to enhance doxorubicin (DOXO) concentrations in tumour cells by drug conjugation with human albumin (HSA). HSA-DOXO has the drawback of causing DOXO accumulation in spleen and bone marrow, with a consequent leucopoenia not produced when lactose molecules are coupled to the carrier protein. In the present experiments we demonstrated that the effect of HSA lactosamination is not a consequence of a more rapid disappearance from the bloodstream of the lactosaminated conjugate (L-HSA-DOXO), which is rapidly internalized by the liver through the asialoglycoprotein receptor, but is due to a hindered uptake by spleen and bone marrow cells caused by the coupled lactose molecules. Experiments in vitro showed that HSA-DOXO produced an inhibition of murine macrophage proliferation not caused by L-HSA-DOXO. This result can be explained by higher amounts of the former conjugate entering in these cells and suggests macrophages as the cell type responsible for the spleen and bone marrow internalization of HSA-DOXO hindered by lactose coupling. Importantly, lactosamination of HSA did not reduce the marked uptake of HSA-DOXO by chemically induced rat hepatocellular carcinoma. L-HSA-DOXO, by avoiding DOXO accumulation in bone marrow is an attractive candidate for clinical trials against tumors which were found to actively internalize this conjugate in laboratory animals, such as hepatocellular carcinoma. 相似文献
6.
Self-expanding mesh stent for endoscopic palliation of rectal obstructing tumors: a preliminary report 总被引:2,自引:0,他引:2
Summary The endoscopic insertion of self-expanding mesh stents in four patients affected by obstructing rectal malignant tumors is reported. The preliminary experience shows that, in the short term, normal defecation was achieved, with no complications. Longer follow-up is necessary to evaluate the duration and the quality of the palliative effect. 相似文献
7.
Pasquale Mastroroberto Massimo Chello Francesco Onorati Attilio Renzulli 《European journal of cardio-thoracic surgery》2005,27(3):531-2; author reply 532
8.
9.
The aim of the present study was to investigate the existence of alterations of the blood-brain barrier (BBB) permeability in rats injected with centrally acting drugs, by calculating a unidirectional blood-to-brain transfer constant (Ki) for the circulating tracer [14C]-alpha-aminoisobutyric acid. The intraperitoneal (i.p.) injection of the dopaminergic antagonist haloperidol (1 mg kg-1) did not modify the regional BBB permeability. When the cholinomimetic agent arecoline hydrobromide (6.25 mg kg-1) was injected i.p. into methylatropine-pretreated rats, it induced a significant decrease of Ki values within the frontal cortex, parietal cortex, striatum and brain-stem. Our findings emphasize two concepts: (1) centrally acting drugs, such as arecoline, can induce changes in the BBB permeability, through several mechanisms; (2) there is no predictable correlation of drug stimulation of specific brain neuronal pathways and changes in the permeability of the BBB. 相似文献
10.